150 related articles for article (PubMed ID: 11745424)
1. Human endostatin inhibits growth of human non-small-cell lung cancer in a murine xenotransplant model.
Boehle AS; Kurdow R; Schulze M; Kliche U; Sipos B; Soondrum K; Ebrahimnejad A; Dohrmann P; Kalthoff H; Henne-Bruns D; Neumaier M
Int J Cancer; 2001 Nov; 94(3):420-8. PubMed ID: 11745424
[TBL] [Abstract][Full Text] [Related]
2. Endostatin inhibits adhesion of endothelial cells to collagen I via alpha(2)beta(1) integrin, a possible cause of prevention of chondrosarcoma growth.
Furumatsu T; Yamaguchi N; Nishida K; Kawai A; Kunisada T; Namba M; Inoue H; Ninomiya Y
J Biochem; 2002 Apr; 131(4):619-26. PubMed ID: 11927001
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.
Chen CT; Lin J; Li Q; Phipps SS; Jakubczak JL; Stewart DA; Skripchenko Y; Forry-Schaudies S; Wood J; Schnell C; Hallenbeck PL
Hum Gene Ther; 2000 Sep; 11(14):1983-96. PubMed ID: 11020798
[TBL] [Abstract][Full Text] [Related]
4. Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth.
Furumatsu T; Nishida K; Kawai A; Namba M; Inoue H; Ninomiya Y
Int J Cancer; 2002 Jan; 97(3):313-22. PubMed ID: 11774282
[TBL] [Abstract][Full Text] [Related]
5. Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes.
Ergün S; Kilic N; Wurmbach JH; Ebrahimnejad A; Fernando M; Sevinc S; Kilic E; Chalajour F; Fiedler W; Lauke H; Lamszus K; Hammerer P; Weil J; Herbst H; Folkman J
Angiogenesis; 2001; 4(3):193-206. PubMed ID: 11911017
[TBL] [Abstract][Full Text] [Related]
6. Antitumor interaction of short-course endostatin and ionizing radiation.
Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of full-length human endostatin on in vitro angiogenesis.
Taddei L; Chiarugi P; Brogelli L; Cirri P; Magnelli L; Raugei G; Ziche M; Granger HJ; Chiarugi V; Ramponi G
Biochem Biophys Res Commun; 1999 Sep; 263(2):340-5. PubMed ID: 10491294
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites.
Hampl M; Tanaka T; Albert PS; Lee J; Ferrari N; Fine HA
Hum Gene Ther; 2001 Sep; 12(14):1713-29. PubMed ID: 11560766
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects.
Abdollahi A; Lipson KE; Sckell A; Zieher H; Klenke F; Poerschke D; Roth A; Han X; Krix M; Bischof M; Hahnfeldt P; Grone HJ; Debus J; Hlatky L; Huber PE
Cancer Res; 2003 Dec; 63(24):8890-8. PubMed ID: 14695206
[TBL] [Abstract][Full Text] [Related]
10. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
Takayama K; Ueno H; Nakanishi Y; Sakamoto T; Inoue K; Shimizu K; Oohashi H; Hara N
Cancer Res; 2000 Apr; 60(8):2169-77. PubMed ID: 10786681
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic and antitumor effects of endostatin on follicular thyroid carcinoma.
Ye C; Feng C; Wang S; Liu X; Lin Y; Li M
Endocrinology; 2002 Sep; 143(9):3522-8. PubMed ID: 12193566
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.
Calvo A; Yokoyama Y; Smith LE; Ali I; Shih SC; Feldman AL; Libutti SK; Sundaram R; Green JE
Int J Cancer; 2002 Sep; 101(3):224-34. PubMed ID: 12209972
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.
Li M; Ye C; Feng C; Riedel F; Liu X; Zeng Q; Grandis JR
Clin Cancer Res; 2002 Nov; 8(11):3570-8. PubMed ID: 12429648
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases.
Sauter BV; Martinet O; Zhang WJ; Mandeli J; Woo SL
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4802-7. PubMed ID: 10758166
[TBL] [Abstract][Full Text] [Related]
15. Influence of adenoviral vector on expression of angiogenesis regulating factors in non-small cell lung cancer cell lines.
Kuhn H; Riedel A; Eichler W; Aust G; Gessner C; Wirtz H
Cancer Immunol Immunother; 2002 Oct; 51(8):461-6. PubMed ID: 12202907
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.
Ding I; Sun JZ; Fenton B; Liu WM; Kimsely P; Okunieff P; Min W
Cancer Res; 2001 Jan; 61(2):526-31. PubMed ID: 11212245
[TBL] [Abstract][Full Text] [Related]
17. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding.
Yamaguchi N; Anand-Apte B; Lee M; Sasaki T; Fukai N; Shapiro R; Que I; Lowik C; Timpl R; Olsen BR
EMBO J; 1999 Aug; 18(16):4414-23. PubMed ID: 10449407
[TBL] [Abstract][Full Text] [Related]
18. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
[TBL] [Abstract][Full Text] [Related]
19. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
Fusetti L; Pruneri G; Gobbi A; Rabascio C; Carboni N; Peccatori F; Martinelli G; Bertolini F
Cancer Res; 2000 May; 60(9):2527-34. PubMed ID: 10811135
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]